PMC 4968649
Research news A University of Texas at El Paso study has found that people with type 2 diabetes or obesity who used glucagon-like peptide-1 receptor agonists had lower odds of alcohol, opioid, nicotine and cocaine use disorders, although researchers said clinical trials were needed before the drugs could be considered for addiction treatment A study led by researchers at The University of Texas at El Paso, USA, has found that the use of diabetes and weight loss medicines such as Ozempic was associated with a lower risk of alcohol, opioid, nicotine and cocaine use disorders
If youlike mestruggle with a feeling of constant hunger and inability to get food off the brain , youve probably dreamt of a weight loss program thats supportive, easy to follow, and (most importantly) effective
If your telehealth or local doctor prescribes the medication, you can have it sent to the local pharmacy of your choice
Anti-obesity medications are an important part of the American Academy of Pediatrics latest guidelines, Saunders said